Position in GILD
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$3,852,738
+$42,889 QoQ
Shares Held
30,495
-1.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#646
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026J.W. COLE ADVISORS, INC. holds $121,333,460 across 13 Drug Manufacturers - General names. GILD ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,412 | $36,477,068 | |
| 2 | JNJ |
Johnson & Johnson
|
113,666 | $28,867,754 | |
| 3 | ABBV |
AbbVie Inc.
|
73,916 | $18,600,222 | |
| 4 | MRK |
Merck & Co., Inc.
|
100,135 | $12,867,347 | |
| 5 | AMGN |
Amgen Inc
|
16,509 | $5,978,239 | |
| 6 | PFE |
Pfizer Inc
|
235,737 | $5,676,546 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
30,495 | $3,852,738 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
59,835 | $3,447,692 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,852,738 | 30,495 | Shares | Sole | 2026-07-21 | |
| 2025-12-31 | $3,809,849 | 31,040 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,383,058 | 30,478 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,558,990 | 23,081 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,434,510 | 21,727 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,255,954 | 13,597 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $1,128,654 | 13,462 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $1,045,547 | 15,239 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,057,162 | 41,736 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $3,392,860 | 41,882 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,940,945 | 39,244 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,717,411 | 35,259 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $2,886,111 | 34,785 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $2,978,479 | 34,694 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,489,191 | 40,350 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $2,402,554 | 38,870 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,276,697 | 38,296 | Shares | Sole | 2022-06-10 | |
| 2021-12-31 | $2,421,180 | 33,345 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $2,183,511 | 31,260 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $2,146,159 | 31,167 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,957,707 | 30,291 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,743,372 | 29,924 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,143,152 | 33,916 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $2,183,326 | 28,377 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $1,114,671 | 14,910 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||